[Polaris Pharmaceuticals-KY] Announcement Regarding the Change of Audit Committee Convener
Polaris Pharmaceuticals-KY announced a change in the Audit Committee convener. Following the expiration of the term of the former convener, Wei Zongde, Zhang Zhigang has been appointed as the new convener.
📋 Article Processing Timeline
- 📰 Published: May 25, 2026 at 09:00
- 🔍 Collected: May 26, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 26, 2026 at 09:07 (1h 6m after Collected)
1. Date of change: May 25, 115
2. Name of the functional committee: Audit Committee
3. Name of the predecessor: Wei Zongde
4. Resume of the predecessor: Professor at China Medical University
5. Name of the successor: Zhang Zhigang
6. Resume of the successor: Zhang Zhigang / CEO of CellGenMed
7. Circumstances of change: Expiration of term
8. Reason for change: Expiration of term
9. Former term: 112/09/26 ~ 115/06/11
10. Effective date of the new appointment: May 25, 115
11. Other notes: Upon the recommendation of the Audit Committee members, committee member Zhang Zhigang was elected as the convener for this term.
2. Name of the functional committee: Audit Committee
3. Name of the predecessor: Wei Zongde
4. Resume of the predecessor: Professor at China Medical University
5. Name of the successor: Zhang Zhigang
6. Resume of the successor: Zhang Zhigang / CEO of CellGenMed
7. Circumstances of change: Expiration of term
8. Reason for change: Expiration of term
9. Former term: 112/09/26 ~ 115/06/11
10. Effective date of the new appointment: May 25, 115
11. Other notes: Upon the recommendation of the Audit Committee members, committee member Zhang Zhigang was elected as the convener for this term.
FAQ
What changed with this personnel announcement?
The convener of the Audit Committee has changed from Wei Zongde to Zhang Zhigang.
Why did this change take place?
It is a routine change due to the expiration of the former convener's term.
What is the background of the new convener?
He serves as the CEO of CellGenMed and is expected to contribute from a professional perspective.